Science
Beam’s Base-Edited Sickle Cell Therapy Meets Pivotal Trial Goal
Beam Therapeutics said its one-time, base-edited cell therapy risto-cel met the main goal of its pivotal BEACON trial in sickle…
Beam Therapeutics said its one-time, base-edited cell therapy risto-cel met the main goal of its pivotal BEACON trial in sickle…